{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-043164","form_type":"8-K","ticker":null,"cik":"0001622879","company_name":"Medicine Man Technologies, Inc.","filed_at":"2024-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.294135+00:00","generated_at":"2026-06-04T02:51:48.893429+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Schwazze Q4 net loss $33.9M; FY23 revenue $172.4M, adjusted EBITDA $53.4M","bullets":["FY2023 revenue $172.4M, income from ops $3.3M; adjusted EBITDA $53.4M (31% of revenue), operating cash flow $12.2M.","Q4 revenue $43.3M (+8% YoY) but net loss $33.9M due to $13.1M non-cash inventory adjustments (obsolescence, NRV, fair value).","Retail footprint expanded 50% to 63 dispensaries via acquisitions of Everest Apothecary, Standing Akimbo, and Smokey’s.","Total debt $156.8M at Dec 31, 2023 vs $127.8M a year earlier; cash $19.2M down from $38.9M.","Interim CEO cites competitive pressure in Colorado and New Mexico; wholesale pricing stabilizing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-043164","json":"https://secwatch.observer/filing/0001104659-24-043164.json","markdown":"https://secwatch.observer/filing/0001104659-24-043164.md","text":"https://secwatch.observer/filing/0001104659-24-043164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924043164/0001104659-24-043164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924043164/tm2411011d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:51:48.893429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a553fefbfabe9ef2c798490ee702705bd4dc6e7","claim":"Medicine Man Technologies, Inc. reported Fourth Quarter 2023 results: revenue $43.3 million.","evidence_excerpt":"Total revenue in the fourth quarter of 2023 increased 8% to $43.3 million compared to $40.1 million for the same quarter last year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924043164/0001104659-24-043164-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Fourth Quarter 2023"},{"label":"Revenue","value":"$43.3 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"c55774cc4a879302e9904702895c49dd5e3db569","claim":"Medicine Man Technologies, Inc. reported Full Year 2023 results: revenue $172.4 Million.","evidence_excerpt":"FY 2023 Revenue of $172.4 Million; Income from Operations of $3.3 Million; Adjusted EBITDA of $53.4 Million or 31% of Revenue","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1622879/000110465924043164/0001104659-24-043164-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Full Year 2023"},{"label":"Revenue","value":"$172.4 Million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}